CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has reached a key milestone in its agreement with Blue Heron Biotechnology and is now the co-exclusive worldwide distributor with Blue Heron for its custom gene synthesis services.
